A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Adults With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Conditions: Dermatitis Atopic Interventions: Drug: Amlitelimab; Drug: Placebo; Drug: Topical corticosteroids; Drug: Topical tacrolimus or pimecrolimus Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Observational Study to Evaluate Use of Elidel ® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Condition: Mild to Moderate Atopic Dermatitis Intervention: Drug: Elidel 1% Topical Cream Sponsor: MEDA PHARMA SPA, a Viatris company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Use of Elidel ® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Conditions: Mild to Moderate Atopic Dermatitis Interventions: Drug: Elidel 1% Topical Cream Sponsors: MEDA PHARMA SPA, a Viatris company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
Condition: Mild to Moderate Atopic Dermatitis Interventions: Drug: IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment; Drug: IN-A002 Ointment 0.5% or IN-A002 Placebo Ointment; Drug: IN-A002 Ointment 1% or IN-A002 Placebo Ointment; Drug: IN-A002 Ointment 3% or IN-A002 Placebo Ointment; Drug: IN-A002 Ointment 5% or IN-A002 Placebo Ointment; Dr ug: IN-A002 Ointment 1%; Drug: IN-A002 Ointment 3%; Drug: Elidel Cream 1% (pimecrolimus) Sponsor: HK inno.N Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2023 Category: Research Source Type: clinical trials
